Paravalvular leak resistant prosthetic heart valve system

1. A method of reducing paravalvular leakage from a prosthetic heart valve, wherein the method comprises:

providing a prosthetic heart valve comprising a stent frame having a surface, a valve structure associated with the stent frame, a sealing mechanism including at least one semi-permeable membrane and an osmotic gradient driving material, wherein the sealing mechanism is positioned at least partially over the surface of the stent frame, wherein the prosthetic heart valve further includes a dissolvable coating layer on the at least one semi-permeable membrane;

deploying the prosthetic heart valve in a patient, wherein the osmotic gradient driving material causes fluid of the patient to pass through the at least one semi-permeable membrane, wherein the fluid that passes through the at least one semi-permeable membrane causes the sealing mechanism to swell and such swelling reduces paravalvular leakage between the prosthetic heart valve and tissue of the patient;

exposing the dissolvable coating layer to at least one of blood and a solvent; and

dissolving the dissolvable coating layer.

2. The method of claim 1 , and further comprising sealing the osmotic gradient driving material within the at least one semi-permeable membrane.

3. The method of claim 1 , wherein the at least one semi-permeable membrane comprises two semi-permeable membranes and wherein the osmotic gradient driving material is placed between the two semi-permeable membranes.

4. The method of claim 1 , wherein the osmotic gradient driving material comprises at least one organic or inorganic compound that is positively or negatively charged.

5. The method of claim 1 , wherein the osmotic gradient driving material comprises at least one inorganic salt and at least one charged organic compound.

6. The method of claim 1 , wherein the at least one semi-permeable membrane is fabricated from a cellulosic material.

7. The method of claim 1 , and further comprising securing the sealing mechanism to the stent frame by at least one of a mechanical fastener and a biocompatible adhesive.

8. The method of claim 1 , wherein the stent frame is expandable from a compressed configuration to an expanded configuration and wherein the valve structure comprises at least two leaflets.

9. The method of claim 1 , wherein the step of exposing the dissolvable coating layer to at least one of blood and a solvent includes exposing the dissolvable coating layer to blood and a solvent.

10. The method of claim 1 , wherein the two semi-permeable membranes include an inner membrane and an outer membrane, and the osmotic gradient driving material is placed between the inner and outer membranes, further wherein the stent frame is positioned between the inner membrane and the outer membrane.

11. A method of reducing paravalvular leakage from a prosthetic heart valve, wherein the method comprises:

providing a prosthetic heart valve including a stent frame having: a surface, a valve structure associated with the stent frame, and a sealing mechanism, wherein the sealing mechanism includes: two semi-permeable membranes including an inner membrane and an outer membrane, and at least one osmotic gradient driving material placed between the inner and outer membranes, further wherein the stent frame is positioned between the inner membrane and the outer membrane; and

deploying the prosthetic heart valve in a patient, wherein the osmotic gradient driving material causes fluid of the patient to pass through the two semi-permeable membranes, wherein the fluid that passes through the two semi-permeable membranes causes the sealing mechanism to swell and such swelling reduces paravalvular leakage between the prosthetic heart valve and tissue of the patient.

12. The method of claim 11 , wherein each of the inner and outer membranes are made of materials having a molecular cutoff range between 1 and 1,000,000 kilodaltons.

13. The method of claim 11 , wherein the prosthetic heart valve further includes a dissolvable coating layer on the outer membrane.

14. The method of claim 13 , wherein the method further includes:

exposing the dissolvable coating layer to blood; and

dissolving the dissolvable coating layer.

15. The method of claim 13 , wherein the method further includes:

exposing the dissolvable coating layer to a solvent; and

dissolving the dissolvable coating layer.